Volume 8, Issue 4 (Autumn 2019)                   Arch Hyg Sci 2019, 8(4): 259-265 | Back to browse issues page


XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Bagheri Z, karimi Z, Ghoreishi R, Daneshpoor Z, Mohebi S. Sleep Quality of Multiple Sclerosis Patients in Qom, Iran, in 2018. Arch Hyg Sci 2019; 8 (4) :259-265
URL: http://jhygiene.muq.ac.ir/article-1-411-en.html
1- a Department of Public Health, Faculty of Health, Qom University of Medical Sciences, Qom, Iran.
2- b Department of Health Education and Health Promotion, Faculty of Health, Qom University of Medical Sciences, Qom, Iran
Full-Text [PDF 621 kb]   (691 Downloads)     |   Abstract (HTML)  (2511 Views)
Full-Text:   (773 Views)
Introduction
Multiple sclerosis (MS) is a relatively common chronic neurological disorder in which the nerve fibers demyelinate in various nerve regions of the central nervous system (1). The cause of the disease is unclear, but it seems that the immune mechanisms are activated against progressed myelin antigen of the disease and may lead to weakness, inability, and dependence on others for daily activities. This disease is considered one of the reasons for the inability of the young workforce. Accordingly, MS is a costly disease due to its incidence in the working-age and chronicity. Based on previous studies, women are three times more likely to get diagnosed with MS, compared to men (2).
Based on the statistics, there are 15-30 cases of MS per 10,000 people. According to the experts in Iran MS Society, 5,000 people are added to this population each year (3). Furthermore, the prevalence of MS varies between women and men since 72% of MS patients are young women and girls while the rest are young active men (4). According to the statistics provided by the World Health Organization, a total of 2.5 million people are afflicted with this disease worldwide, 500,000 and 400,000 of whom are in Europe and North America, respectively (5). The disease is so prevalent that it is known as the most common disease of the century, and is the third leading cause of disability in the United States (6).
According to previous research, genetics, distance from the equator, and socioeconomic status are among the factors contributing to the prevalence of the disease (7). A study revealed that 9.17%, 8.38%, 2.11%, and 9.14% of MS patients had severe physical problems, social problems, depression, and anxiety (8). Another common problem in MS patients which causes severe impairment is poor sleep quality and sleep disorders (9).
Sleep disorders include difficulty falling asleep (sleep-onset latency of more than 30 min) and nocturnal awakening (more than once) (10). Such disorders can cause problems, including drowsiness, lethargy during the day, stress, anxiety, headache, and disturbance in daily routine (11). More than 50% of MS patients suffer from sleep disorders; therefore, it can be said that they experience sleep-related issues more than other chronic disease patients and other people in general. Furthermore, previous studies have revealed that female MS patients are more likely to have such problems, compared to men (12).
According to recent studies, sleep deprivation, inadequate sleep, and sleep disorders can potentially decrease the quality of life and increase the risk of death. Sleep disorders cause pathological, mental and neurological problems, as well as fatigue. Moreover, MS patients with sleep disorders suffer from concentration and learning disorders, and mood swings (14). Given the increasing prevalence of MS, its subsequent high risk of mortality, high costs, and many other problems, special attention should be paid to these patients and efforts should be made to reduce their problems. Based on the author's knowledge and the review of related literature, no similar study had been conducted in Qom province, Iran. Therefore, the present study was conducted to determine the quality of sleep in MS patients in Qom, in 2018.
Materials and Methods
The present cross-sectional study was performed on 272 MS patients who were members of MS society, in Qom. Samples were selected through random sampling method from a list of files in the MS society Center. Subsequently, the samples were called on their phones and asked to participate in the study. The inclusion criteria were willingness to participate and age range of 20-60 years. On the other hand, exclusion criteria were being within the first 2 years of the disease, in the advanced stages of the disease, or non-Iranian. Ethical considerations were respected in the current study. In this regard, the purpose of the study was explained for the participants, the information was kept confidential, and the subjects were informed of the dissemination of a general report of the research results. Moreover, informed consent was obtained from the research participants.
A demographic characteristics form and Pittsburgh Sleep Quality Index (PSQI) were used for data collection. PSQI measures 7 aspects of sleep through 19 items, namely subjective sleep quality, prolonged sleep onset latency, sleep duration, sleep efficiency, sleep disorders, usage of hypnotic medications, and disturbance in daily routine. Each aspect was scored based on a scale from zero (no disorders) to three (severe disorders). To calculate the overall sleep quality score, the scores for each aspect were added to each other and a total score was achieved (0-21). A high score in each domain or the total score indicates poor sleep quality (15, 16). The validity and reliability of the abovementioned questionnaire have been confirmed in previous studies. The validity of the questionnaire was confirmed by Hosseinabadi et al. (r=0.88) and Soleimani et al. (r=0.84) through test-retest (17, 18). Moreover, the reliability of the questionnaire was verified through content and face validity tests by six faculty members of Faculty of Nursing and Midwifery, Azad University, Isfahan (Khorasgan) Branch, Iran (19).
 
The data were collected by a trained interviewer who was supposed to complete the questionnaires after interviewing the patients. Subsequently, the collected data were analyzed in SPSS software (version 21) using descriptive statistics and analytical tests, including independent t-test, ANOVA, and a post hoc test (i.e., Duncan). A p-value of less than 0.05 was considered statistically significant.
Results
Mean age of the participants was 37.95±9.14 years. Furthermore, the mean of disease duration in MS patients was 6.18±5.08 years. The rest of the demographic characteristics of the study subjects are presented in Table 1.
Table 1. Frequency distribution of demographic characteristics of the subjects
Demographic characteristics Number Percentage
Gender Male 98 36
Female 174 64
Marital status Single 80 29.4
Married 192 70.6
Occupation Self-employed 144 52.9
Governmental 81 29.8
Housewife 45 16.5
Unemployed 2 0.7
Financial status 1< million Tomans 76 27.9
1-2 million Tomans 76 27.9
2-3 million Tomans 65 23.9
<3 million Tomans 37 13.6
No income 18 6.6
 
Mean score of sleep quality in the studied samples was 11.11±4.35. A total of 33.8%, 48.2%, and 12.86% had mild, moderate, and severe sleep disorders, whereas 14.5% had no sleep disorders. Table 2 shows the frequency and percentage of sleep quality status and its subscales in the subjects of the study.
 
Table 2. Frequency distribution of sleep quality aspects in the subjects
Sleep quality aspects No sleep disorder Mild sleep disorder Moderate sleep disorder Severe sleep disorder
Subjective sleep quality (23) 8.5% (100) 36.8% (96) 35.3% (53) 19.5%
Prolonged sleep onset latency (41) 15.1% (82) 30.1% (99) 36.4% (50) 18.4%
Sleep duration (66) 24.3% (82) 25.7% (67) 24.6% (69) 25.4%
Sleep efficiency 0 0 0 100%
Sleep disorders (4) 1.5% (137) 50.4% (108) 39.7% (23) 8.5%
Usage of hypnotic medications (97) 35.7% (72) 26.56% (63) 23.2% (40) 14.7%
Disturbance in daily routine (47) 17.3% (102) 37.5% (86) 31.6% (13.6% (37
Total sleep quality (14)5.14% (92)33.8% (131)48.2 (35)12.86%
 
 
According to the results of the independent t-test, there was no significant relationship between gender and sleep quality aspects (P<0.05). However, the independent t-test results showed a significant association between the mean sleep quality score (total score) and marital status (P=0.005) Moreover, there was a significant relationship between sleep disorders aspect and marital status (P<0.001).
Results of data analysis using ANOVA showed that the mean score of sleep quality (total score) had a statistically significant relationship with the occupations of the subjects (P=0.041). Accordingly, Duncan's test showed that the mean score of sleep quality of housewives was significantly lower than that of the other groups, while the sleep quality score of the unemployed subjects was significantly higher than that of the other groups. Furthermore, the ANOVA test showed no significant relationship between the mean score of sleep quality aspects and income (P> 0.05).
 
The sleep quality score had a significant correlation with age (r=0.409, P<0.001) and disease duration (r=0.367, P<0.001). Table 3 shows the correlation of sleep quality aspects with age and disease duration of participants.
 
Table 3. Correlation of sleep quality aspects with the age and disease duration
 
Demographic characteristics Subjective sleep quality Prolonged sleep onset latency Sleep duration Sleep efficiency Sleep disorders Consumption of hypnotic medications Disturbance in daily routine Sleep quality (total score)
Age r 0.286 0.209 0.250 0.291 0.379 0.369 0.119 0.409
P 0.001> <0.001 <0.001 <0.001 <0.001 <0.001 0.050 <0.001
Disease duration r 0.299 0.245 0.194 0.148 0.288 0.381 0.045 0.367
P <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 0.456 <0.001
 
 
Discuss
The results of the present study, which aimed to determine the sleep quality of MS patients in Qom during 2018, revealed that about 95% of the subjects had moderate to severe sleep disorders. This finding was in line with those of previous studies which showed that more than 50% of MS patients suffered from poor sleep quality. Similarly, in a study performed by Sahraian et al, 87.5% of MS patients had poor sleep quality (20). Moreover, in another study conducted by Kotterba et al., sleep disorder was observed in 55.47% of MS patients (21). Veauthier et al. in their study also reported that 96% of MS patients suffering from fatigue, had sleep disorders as well (22). In general, poor sleep quality is a common issue among MS patients (23). According to previous research, sleep disorders and poor sleep quality are more prevalent in MS patients, compared to the public and patients with other chronic diseases (12). The high prevalence of such issues in these patients can be due to restless legs syndrome, pain, waking up for urination, and chronic fatigue (9, 24).
According to the results, there was a significant relationship between sleep quality and marital status of MS patients so that single people had a better sleep quality. Similarly, other previous studies have revealed that marital status had a significant association with sleep quality and that single people had a better sleep quality (25) which could be due to the fact that married people are more occupied with thoughts about various difficulties. It can be said that married MS patients are more concerned due to their responsibilities toward their children and other family members, the anxiety associated with their illness, and fear of the future, which finally results in poor sleep quality. However, some studies revealed that the sleep quality of married people is better (26), which may be due to differences in the statistical population of the study.
Based on the findings, there is a significant relationship between the occupation of patients and their sleep quality. Therefore, the quality of sleep in housewives was better than that in people with other occupations. Moreover, the present study revealed that unemployed people had poor sleep quality. This is in line with the results of other studies conducted by Arasteh et al., Zargarian et al., Adams et al., and Friedman et al. which have shown that people with a better socioeconomic status have better sleep quality (25) (27-29). Given the economic burden of MS, it is important to have a job that provides the patients with enough money. Moreover, the interactions between coworkers can be effective, regarding the provision of social support and mental peace which can affect their sleep quality (26).
In addition, a significant relationship was observed between disease duration and sleep quality which is consistent with the findings of a study performed by Vitkova et al. (30). Moreover, based on the results, the disease duration has a significant association with poor sleep quality. Furthermore, it was revealed that the progressive disease complications, decreased quality of life, and increasing age of the patient are effective factors resulting in the decrease of sleep quality (9, 31, 32). The results showed that there is a negatively significant relationship between the age of patients and their sleep quality which is in line with the findings of studies conducted by Tabrizi et al. (33) and Motaharinejad et al. (34) which revealed that sleep quality decreases with age (26). Furthermore, findings showed that there was no significant relationship between gender and sleep quality which is in line with that of a study performed by Merlino et al. (35). However, it is inconsistent with the results of the studies conducted by Vitkova et al. (30), and Leonavicius et al. (32) which could be due to a difference in the study populations.
In the present study, the highest prevalence of poor sleep quality was related to the aspects of sleep efficiency and sleep duration. A total of 100% of patients had very poor sleep efficiency and about 26% of them had severe sleep problems. Depression, fatigue, pain, nocturnal awakenings, daytime sleepiness, spasms, and restless legs syndrome are major causes of sleep issues in MS patients (21, 32, 36, 37).
One of the limitations was that the subjects were selected from the MS Society in Qom; consequently, the results cannot be generalized to all of the MS patients. The present study did not investigate the causes of poor sleep quality; therefore, future studies are recommended to investigate the causes and predictors of effective factors on sleep quality in MS patients. Moreover, it is suggested to conduct interventional studies in order to improve the sleep quality of these patients. Results of such studies can be used to evaluate the degree of poor sleep quality in MS patients. Moreover, the decision-makers can utilize the findings to develop programs in order to improve the patients’ sleep quality, thereby enhancing their quality of life.
Conclusion
The results showed that poor sleep quality is a common problem in MS patients. Moreover, since the symptoms of this disease affect sleep quality, it is necessary to provide them with interventions. These interventions should include special training to improve symptoms, sleep hygiene, and sleep quality. Therefore, it is recommended to include regular sleep hygiene and sleep quality improvement training along with the routine care of such patients.
Funding
This study was extracted from a thesis (IR.MUQ.REC.1396.12) which was financially supported by the Research and Technology Deputy of Qom University of Medical Sciences.
Conflict of Interest
The authors declare no conflict of interest in this article.
Acknowledgments
The authors would like to thank the Research and Technology Deputy of Qom University of Medical Sciences, the officials and staff of MS Society in Qom, as well as all the patients who participated in the study.
 
Type of Study: Original Article | Subject: General
Received: 2019/09/4 | Accepted: 2020/01/20 | Published: 2020/02/8

References
1. Eslami G, Hashemi A, Karimi Yazdi MM, Esmaeili Benvidi M, Khiabani Rad P, Moradi S ; Fallah F and et al. Antibacterial Effects of Zataria multiflora, Ziziphus, Chamomile and Myrtus communis Methanolic Extracts on IMP-Type Metallo-Beta-Lactamase-Producing Pseudomonas aeruginosa. Arch Clin Infect Dis. 2016; 11(1): e32413 , doi: 10.5812 [DOI:10.5812/archcid.32413]
2. Franco M, Caiaffa-Filho H, Burattini M, Rossi F. Metallo-beta-lactamases among imipenem-resistant P. aeruginosa in a Brazilian university hospital. Clinics (Sao Paulo) 2010; 65:825-829. PubMed: PMC2954731. [DOI:10.1590/S1807-59322010000900002]
3. Peng Y, Shi J, Bu T, Li Y, Ye X, Chen X, Yaoa Z. Alarming and increasing prevalence of multidrug resistant Pseudomonas aeruginosa among healthcare-associated infections in China. JGAR 2015; 3: 155-160. doi: 10.1016/j.jgar.2015.04.001. [DOI:10.1016/j.jgar.2015.04.001]
4. Teixeira B, Rodulfo H, Carreño N, Guzmán M, Salazar E, De Donato A. Aminoglycoside resistance genes in pseudomonas aeruginosa isolates from cumana, Venezuela. Rev Inst Med Trop Sao Paulo. 2016; 58: 13. doi: 10.1590/S1678-9946201658013. PMID: 27007556. [DOI:10.1590/S1678-9946201658013]
5. Islam S, Oh H, Jalal S, Karpati F, Ciofu O, Høiby N, et al. Chromosomal mechanisms of aminoglycoside resistance in Pseudomonas aeruginosa isolates from cystic fibrosis patients. Clin Microbiol Infect. 2009; 15:60-6. doi: 10.1111/j.1469-0691.2008.02097.x. [DOI:10.1111/j.1469-0691.2008.02097.x]
6. Sadovskay I, Vinogradov E, Li J, Hachani A, Kowalska K, Filloux A. H igh-level antibiotic resistance in Pseudomonas aeruginosa biofilm: then dvB gene is involved in the production of highly glycerol-phosphory lated b-(1 R3)-glucans, which bind aminoglycosides. Glycobiol. 2010; 20: 895-904, doi: 10.1093/glycob/cwq047. [DOI:10.1093/glycob/cwq047]
7. Ramirez MS, Tolmasky ME. Aminoglycoside modifying enzymes. Drug Resist Updates 2010;13(6):151-171. doi: 10.1016/j.drup.2010.08.003. [DOI:10.1016/j.drup.2010.08.003]
8. Poole K. Pseudomonas aeruginosa: resistance to the max. Front Microbiol. 2011; 2: 65. doi: 10.3389/fmicb.2011.00065. [DOI:10.3389/fmicb.2011.00065]
9. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; twenty first informational supplement. CLSI document M100-S21. CLSI 2011 Wayne, PA.
10. Chatterjee M, Anju CP, Biswas L, Anil Kumar V, Gopi Mohan C, Biswas R. Antibiotic resistance in Pseudomonas aeruginosa and alternative therapeutic options. Int J Med Microbiol. 2016; 306(1): 48-58. PMID: 26687205 DOI: 10.1016/j.ijmm.2015.11.004. [DOI:10.1016/j.ijmm.2015.11.004]
11. Tarashi S, Goudarzi H, Erfanimanesh S, Pormohammad A, HashemiA. Phenotypic and Molecular Detection of Metallo-Beta-Lactamase Genes Among Imipenem Resistant Pseudomonas aeruginosa and Acinetobacter baumannii Strains Isolated From Patients with Burn Injuries. Arch Clin Infect Dis. 2016; 11(4): e39036. doi: 10.5812/archcid.39036. [DOI:10.5812/archcid.39036]
12. Adabi M, Talebi Taher M, Arbabi L, Afshar M, Fathizadeh S, Minaeian S, et al. Determination of Antibiotic Resistance Pattern of Pseudomonas aeruginosa Strains Isolated from Patients with Burn Wounds . J Ardabil Univ Med Sci. 2015; 15 (1): 66-74.
13. Goudarzi H, Taherpour A, Fallah F, Pourkaveh B, Erfanimanesh S, Hashemi A. Laboratory Detection of Carbapenemases in Gram-Negative Bacteria. Arch Clin Infect Dis. 2016; 11(2):e32816. doi: 10.5812/archcid.32816. [DOI:10.5812/archcid.32816]
14. Michalska AD, Sacha PT, Ojdana D, Wieczorek A, Tryniszewska E. Prevalence of resistance to aminoglycosides and fluoroquinolones among Pseudomonas aeruginosa strains in a University Hospital in Northeastern Poland. Braz J Microbiol. 2014; 45(4): 1455-8. PMID: 25763054. [DOI:10.1590/S1517-83822014000400041]
15. Bhatt P, Rathi KR, Hazra S, Sharma A, Shete V. Prevalence of multidrug resistant Pseudomonas aeruginosa infection in burn patients at a tertiary care centre. India J Burns. 2015; 23(1): 56. . doi: 10.4103/0971- 653X.171656. [DOI:10.4103/0971-653X.171656]
16. Kashfi M, Hashemi A, Eslami G, Sadredin Amin M, Tarashi S, et al. The Prevalence of Aminoglycoside-Modifying Enzyme Genes Among Pseudomonas aeruginosa Strains Isolated From Burn Patients, Arch Clin Infect Dis. 2017; 12(1):e40896. doi: 10.5812/archcid.40896. [DOI:10.5812/archcid.40896]
17. Vaziri F, Peerayeh SN, Nejad QB, Farhadian A. The prevalence of aminoglycoside-modifying enzyme genes (aac (6')-I, aac (6')-II, ant (2")-I, aph (3')-VI) in Pseudomonas aeruginosa. Clinics (Sao Paulo). 2011; 66(9):1519-22. doi:org/10.1590/S1807-59322011000900002.
18. Dubois V, Arpin C, Dupart V, Scavelli A, Coulange L, Andre C, et al. Beta-lactam and aminoglycoside resistance rates and mechanisms among Pseudomonas aeruginosa in French general practice (community and private healthcare centres). J Antimicrob Chemother. 2008; 62(2):316-23. doi: 1 0.1093/jac/dkn174. [DOI:10.1093/jac/dkn174]
19. Asghar A, Ahmed O. Prevalence of aminoglycoside resistance genes in Pseudomonas aeruginosa isolated from a tertiary care hospital in Makkah, KSA. Clinical Practice (Therapy) 2018; 15(2): 1-7. [DOI:10.4172/clinical-practice.1000391]
20. Kim JY, Park YJ, Kwon HJ, Han K, Kang MW, Woo GJ. Occurrence and mechanisms of amikacin resistance and its association with beta-lactamases in Pseudomonas aeruginosa: a Korean nationwide study. J Antimicrob Chemother. 2008; 62(3):479-83. doi: 10.1093/jac/dkn244. [DOI:10.1093/jac/dkn244]
21. Eslami G, Hashemi A, Karimi Yazdi MM, Esmaeili Benvidi M, Khiabani Rad P, Moradi S ; Fallah F and et al. Antibacterial Effects of Zataria multiflora, Ziziphus, Chamomile and Myrtus communis Methanolic Extracts on IMP-Type Metallo-Beta-Lactamase-Producing Pseudomonas aeruginosa. Arch Clin Infect Dis. 2016; 11(1): e32413 , doi: 10.5812 [DOI:10.5812/archcid.32413]
22. Franco M, Caiaffa-Filho H, Burattini M, Rossi F. Metallo-beta-lactamases among imipenem-resistant P. aeruginosa in a Brazilian university hospital. Clinics (Sao Paulo) 2010; 65:825-829. PubMed: PMC2954731. [DOI:10.1590/S1807-59322010000900002]
23. Peng Y, Shi J, Bu T, Li Y, Ye X, Chen X, Yaoa Z. Alarming and increasing prevalence of multidrug resistant Pseudomonas aeruginosa among healthcare-associated infections in China. JGAR 2015; 3: 155-160. doi: 10.1016/j.jgar.2015.04.001. [DOI:10.1016/j.jgar.2015.04.001]
24. Teixeira B, Rodulfo H, Carreño N, Guzmán M, Salazar E, De Donato A. Aminoglycoside resistance genes in pseudomonas aeruginosa isolates from cumana, Venezuela. Rev Inst Med Trop Sao Paulo. 2016; 58: 13. doi: 10.1590/S1678-9946201658013. PMID: 27007556. [DOI:10.1590/S1678-9946201658013]
25. Islam S, Oh H, Jalal S, Karpati F, Ciofu O, Høiby N, et al. Chromosomal mechanisms of aminoglycoside resistance in Pseudomonas aeruginosa isolates from cystic fibrosis patients. Clin Microbiol Infect. 2009; 15:60-6. doi: 10.1111/j.1469-0691.2008.02097.x. [DOI:10.1111/j.1469-0691.2008.02097.x]
26. Sadovskay I, Vinogradov E, Li J, Hachani A, Kowalska K, Filloux A. H igh-level antibiotic resistance in Pseudomonas aeruginosa biofilm: then dvB gene is involved in the production of highly glycerol-phosphory lated b-(1 R3)-glucans, which bind aminoglycosides. Glycobiol. 2010; 20: 895-904, doi: 10.1093/glycob/cwq047. [DOI:10.1093/glycob/cwq047]
27. Ramirez MS, Tolmasky ME. Aminoglycoside modifying enzymes. Drug Resist Updates 2010;13(6):151-171. doi: 10.1016/j.drup.2010.08.003. [DOI:10.1016/j.drup.2010.08.003]
28. Poole K. Pseudomonas aeruginosa: resistance to the max. Front Microbiol. 2011; 2: 65. doi: 10.3389/fmicb.2011.00065. [DOI:10.3389/fmicb.2011.00065]
29. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; twenty first informational supplement. CLSI document M100-S21. CLSI 2011 Wayne, PA.
30. Chatterjee M, Anju CP, Biswas L, Anil Kumar V, Gopi Mohan C, Biswas R. Antibiotic resistance in Pseudomonas aeruginosa and alternative therapeutic options. Int J Med Microbiol. 2016; 306(1): 48-58. PMID: 26687205 DOI: 10.1016/j.ijmm.2015.11.004. [DOI:10.1016/j.ijmm.2015.11.004]
31. Tarashi S, Goudarzi H, Erfanimanesh S, Pormohammad A, HashemiA. Phenotypic and Molecular Detection of Metallo-Beta-Lactamase Genes Among Imipenem Resistant Pseudomonas aeruginosa and Acinetobacter baumannii Strains Isolated From Patients with Burn Injuries. Arch Clin Infect Dis. 2016; 11(4): e39036. doi: 10.5812/archcid.39036. [DOI:10.5812/archcid.39036]
32. Adabi M, Talebi Taher M, Arbabi L, Afshar M, Fathizadeh S, Minaeian S, et al. Determination of Antibiotic Resistance Pattern of Pseudomonas aeruginosa Strains Isolated from Patients with Burn Wounds . J Ardabil Univ Med Sci. 2015; 15 (1): 66-74.
33. Goudarzi H, Taherpour A, Fallah F, Pourkaveh B, Erfanimanesh S, Hashemi A. Laboratory Detection of Carbapenemases in Gram-Negative Bacteria. Arch Clin Infect Dis. 2016; 11(2):e32816. doi: 10.5812/archcid.32816. [DOI:10.5812/archcid.32816]
34. Michalska AD, Sacha PT, Ojdana D, Wieczorek A, Tryniszewska E. Prevalence of resistance to aminoglycosides and fluoroquinolones among Pseudomonas aeruginosa strains in a University Hospital in Northeastern Poland. Braz J Microbiol. 2014; 45(4): 1455-8. PMID: 25763054. [DOI:10.1590/S1517-83822014000400041]
35. Bhatt P, Rathi KR, Hazra S, Sharma A, Shete V. Prevalence of multidrug resistant Pseudomonas aeruginosa infection in burn patients at a tertiary care centre. India J Burns. 2015; 23(1): 56. . doi: 10.4103/0971- 653X.171656. [DOI:10.4103/0971-653X.171656]
36. Kashfi M, Hashemi A, Eslami G, Sadredin Amin M, Tarashi S, et al. The Prevalence of Aminoglycoside-Modifying Enzyme Genes Among Pseudomonas aeruginosa Strains Isolated From Burn Patients, Arch Clin Infect Dis. 2017; 12(1):e40896. doi: 10.5812/archcid.40896. [DOI:10.5812/archcid.40896]
37. Vaziri F, Peerayeh SN, Nejad QB, Farhadian A. The prevalence of aminoglycoside-modifying enzyme genes (aac (6')-I, aac (6')-II, ant (2")-I, aph (3')-VI) in Pseudomonas aeruginosa. Clinics (Sao Paulo). 2011; 66(9):1519-22. doi:org/10.1590/S1807-59322011000900002.
38. Dubois V, Arpin C, Dupart V, Scavelli A, Coulange L, Andre C, et al. Beta-lactam and aminoglycoside resistance rates and mechanisms among Pseudomonas aeruginosa in French general practice (community and private healthcare centres). J Antimicrob Chemother. 2008; 62(2):316-23. doi: 1 0.1093/jac/dkn174. [DOI:10.1093/jac/dkn174]
39. Asghar A, Ahmed O. Prevalence of aminoglycoside resistance genes in Pseudomonas aeruginosa isolated from a tertiary care hospital in Makkah, KSA. Clinical Practice (Therapy) 2018; 15(2): 1-7. [DOI:10.4172/clinical-practice.1000391]
40. Kim JY, Park YJ, Kwon HJ, Han K, Kang MW, Woo GJ. Occurrence and mechanisms of amikacin resistance and its association with beta-lactamases in Pseudomonas aeruginosa: a Korean nationwide study. J Antimicrob Chemother. 2008; 62(3):479-83. doi: 10.1093/jac/dkn244. [DOI:10.1093/jac/dkn244]

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2025 CC BY-NC 4.0 | Archives of Hygiene Sciences

Designed & Developed by : Yektaweb